IL2RB and cancer: BLCA (R = 0.605, P < 0.001), CESC (R = 0.426, P < 0.001), and CHOL (R = 0.712, P < 0.001) were the top three cancers with the most remarkable correlation between IL2RB contents with immune score among 33 cancers (Figure 5(b)).